Xencor | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 38.75B 4.31B 2024-12
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amgen USD 23.01B 91M 2025-03
Arrowhead Research USD 93.76M 9.41M 2024-12
AstraZeneca USD 29.13B 1.26B 2025-03
Biogen USD 5.3B 231.4M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Cytokinetics USD 179.67M 69.86M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
J&J USD 56.9B 6.58B 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Xencor USD 87.43M 4.54M 2024-12



Xencor Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.